Literature DB >> 1865215

Early heparin therapy in patients with spontaneous intracerebral haemorrhage.

A Boeer1, E Voth, T Henze, H W Prange.   

Abstract

In 68 patients with spontaneous intracerebral haemorrhage the effect of heparin treatment beginning on the second, fourth or tenth day was investigated. Early (day 2) low-dose heparin medication significantly lowered the incidence of pulmonary embolism. An increase in the number of patients with rebleeding was not observed. The results indicate that the early use of heparin in these patients is safe and can be recommended for the prevention of thromboembolic complications.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1865215      PMCID： PMC488553          DOI： 10.1136/jnnp.54.5.466

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  10 in total

1.  The clinical spectrum of hemorrhagic infarction.

Authors:  B R Ott; A Zamani; J Kleefield; H H Funkenstein
Journal:  Stroke       Date:  1986 Jul-Aug       Impact factor: 7.914

2.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

3.  Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage.

Authors:  U Dickmann; E Voth; H Schicha; T Henze; H Prange; D Emrich
Journal:  Klin Wochenschr       Date:  1988-12-01

4.  99mTc red blood cell venography in deep vein thrombosis of the leg: a correlation with contrast venography.

Authors:  R Lisbona; J Stern; V Derbekyan
Journal:  Radiology       Date:  1982-06       Impact factor: 11.105

5.  Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke.

Authors:  S T McCarthy; J J Turner; D Robertson; C J Hawkey; D J Macey
Journal:  Lancet       Date:  1977-10-15       Impact factor: 79.321

Review 6.  Prophylaxis of postoperative thromboembolic complications with low-dose heparin. An analysis of different administration intervals.

Authors:  D Bergqvist
Journal:  Acta Chir Scand       Date:  1979

7.  Detection of deep venous thrombosis by scanning of 99mtechnetium-labelled red-cell venous pool.

Authors:  W Beswick; R Chmiel; R Booth; I Vellar; E Gilford; C N Chesterman
Journal:  Br Med J       Date:  1979-01-13

8.  Visualizing cardiac blood pool: comparison of three labeling methods.

Authors:  P Neumann; H Schicha; P Schürnbrand; M Bähre; D Emrich
Journal:  Eur J Nucl Med       Date:  1983

9.  [Prevention of venous thrombosis in recent ischaemic cerebrovascular accident: double-blind study with heparin-dihydroergotamine (author's transl)].

Authors:  B Czechanowski; F Heinrich
Journal:  Dtsch Med Wochenschr       Date:  1981-09-25       Impact factor: 0.628

10.  Dosage in low-dose heparin prophylaxis.

Authors:  J Seglias; U F Gruber
Journal:  Haemostasis       Date:  1979
  10 in total
  30 in total

1.  Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.

Authors:  Stephan A Mayer; Nikolai C Brun; Joseph Broderick; Stephen M Davis; Michael N Diringer; Brett E Skolnick; Thorsten Steiner
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

2.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

3.  Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Maarten G Lansberg; Martin J O'Donnell; Pooja Khatri; Eddy S Lang; Mai N Nguyen-Huynh; Neil E Schwartz; Frank A Sonnenberg; Sam Schulman; Per Olav Vandvik; Frederick A Spencer; Pablo Alonso-Coello; Gordon H Guyatt; Elie A Akl
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 4.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

Review 5.  Should anticoagulation be resumed after intracerebral hemorrhage?

Authors:  Joshua N Goldstein; Steven M Greenberg
Journal:  Cleve Clin J Med       Date:  2010-11       Impact factor: 2.321

6.  Risk of thromboembolism following acute intracerebral hemorrhage.

Authors:  Joshua N Goldstein; Louis E Fazen; Lauren Wendell; Yuchiao Chang; Natalia S Rost; Ryan Snider; Kristin Schwab; Rishi Chanderraj; Christopher Kabrhel; Catherine Kinnecom; Emilie Fitzmaurice; Eric E Smith; Steven M Greenberg; Jonathan Rosand
Journal:  Neurocrit Care       Date:  2008-09-23       Impact factor: 3.210

7.  Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine.

Authors:  Michel T Torbey; Julian Bösel; Denise H Rhoney; Fred Rincon; Dimitre Staykov; Arun P Amar; Panayiotis N Varelas; Eric Jüttler; DaiWai Olson; Hagen B Huttner; Klaus Zweckberger; Kevin N Sheth; Christian Dohmen; Ansgar M Brambrink; Stephan A Mayer; Osama O Zaidat; Werner Hacke; Stefan Schwab
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

8.  Interpretation and Implementation of Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT II).

Authors:  Adnan I Qureshi; Yuko Y Palesch; Renee Martin; Kazunori Toyoda; Haruko Yamamoto; Yongjun Wang; Yilong Wang; Chung Y Hsu; Byung-Woo Yoon; Thorsten Steiner; Kenneth Butcher; Daniel F Hanley; Jose I Suarez
Journal:  J Vasc Interv Neurol       Date:  2014-06

Review 9.  Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management.

Authors:  Thomas J Cusack; J Ricardo Carhuapoma; Wendy C Ziai
Journal:  Curr Treat Options Neurol       Date:  2018-02-03       Impact factor: 3.598

Review 10.  Clinical review: Critical care management of spontaneous intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.